Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: The presenters will provide an overview of the current state of the Group Life product space.

Description: In session 28TS of the Montreal Spring Meeting panelists discuss issues related to retention limits for individual life and disability income DI reinsurance. From the Record of the Society of Actuaries, Vol. 23, No. 2.

Description: This presentation, session number 102PD, took place at the 1999 Spring Meeting of the Society of Actuaries, held June 16-18 in Seattle. The panelists discuss the popularity of such voluntary products as critical illness, group AD&D, and group long-term disability, and their implications for reinsurers. Discussion from participants is included. From the Record of the Society of Actuaries, Vol. 25, No. 2.

Description: Panelists at this session of the SOA 2001 Toronto Spring Meeting discuss incorporating reinsurance costs into the pricing of their retail products. Panelists also discuss the different effects of various reinsurance arrangements.

Description: Discusses the reinsurance arbitration process and then holds a mock arbitration hearing to illustrate the process. From the 1988 Record of Society of Actuaries, Vol. 14, No. 4A.

Description: This session discussion is about persistency influence the profitability of individual life reinsurance. From Record of the Society of Actuaries Vol. 15, No. 2.

Description: Session 9 of the 1990 Valuation Actuary Symposium is an open forum on reinsurance.

Description: Panelists discuss Lloyd's of London, its past difficulties, and its future role in the reinsurance market. From the Record of the Society of Actuaries, Vol. 23, No. 1.

Description: This session from the 2003 SOA Washington D.C. Meeting covers recent issues surrounding quota share reinsurance, including limits in the capital market, XXX reserves, letter of credit funding and costs, recapture provisions and arbitration. From the Record of the Society of Actuaries, Volume 29, No. 1, Session 3pd.